-
Report details
-
8
Figures
-
9
Tables
-
Chapter 1: Executive Summary
-
Introduction
-
Product Introductions, Indications of Price Pressure
-
Stability in Sequencers Appears to Be Continuing
-
A Period of Rapid Adoption, But Lower Prices
-
High Likelihood of Longer-Term Challenges
-
Size and Growth of the Market
-
Scope and Methodology
-
Applications and Definitions
-
Chapter 2: Trends
-
Falling Costs, Improved Output, Smaller and Simpler
-
Broad Range of Deals and Acquisitions
-
New Technologies Continuing to Push Boundaries
-
China Becoming Major Player in Market
-
More Systems Stalled or Cancelled
-
Gradual Acceptance and Validation of Clinical Applications
-
Settlement or Resolution of Litigation
-
Success in Microbiology and Pathogen Detection
-
Regulatory Trends
-
Chapter 3: Products
-
Chapter 4: Revenues
-
Revenues Forecast
-
Revenues by Region
-
Illumina Sequencing Consumables Revenues
-
Chapter 5: Competitive
-
Introduction
-
Continued Growth and Technology Advances
-
Sequencer Battles Turn Somewhat Calm
-
Library Preparation and Target Enrichment Market Shares
-
Smaller Companies Experiencing Mixed Success
-
Chapter 6: Deals
-
Chapter 7: Corporate Profiles
-
10X Genomics
-
Agilent Technologies
-
Fluidigm
-
Illumina
-
Oxford Nanopore
-
Pacific Biosciences
-
Qiagen
-
Roche
-
Thermo Fisher Scientific
-
Chapter 8: Challenges
-
Challenges
-
Highly Concentrated Sequencer Market Increases Risks
-
Challenges Arising with Clinical Trials
-
Dropping Sequencing Costs Create Complex Situations
-
Potential for Disruptive Technology or Litigation
-
Diagnoses, Treatments, Ethics Still Inexact
-
Unknown Effects of Closed Systems, Automation, Streamlining
-
Some Advances Can Reduce Markets
-
Sample Preparation Customer Loyalty Lacking
-
Shortcomings and Pitfalls Require Solutions
-
Low Barriers Can Increase Competition Short-Term
-
Cautious Approach with LDT Regulation
-
Complexity and Difficulty Restrains Broad Adoption
-
Many Labs Opting for Services over Purchasing Sequencers
-
Strategic Recommendations
-
Diversify Products and Applications
-
Expanding Market Requires Technical Support
-
Reduce Bias, Compensate, or Characterize It
-
Capitalize on Stability While Preparing for Contingencies
-
Address or Anticipate Price Pressure
-
Benefit from Partnering or Communicating
-
Use Services for Visibility and Monetization
-
Address or Ease Data Analysis Challenges
-
Anticipate or Position for Global Adoption
|
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) 2021
29 Jul 2021
SKU: 21-030
This report, Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) 2021, examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, Europe, Asia-Pacific, rest-of-world).
The introduction of smaller, cheaper benchtop NGS systems has expanded the market into smaller labs that could never afford prices for earlier systems. Due to their lower throughput, they are suitable for a variety of applications but not for most whole genome sequencing. With the high performance provided by these smaller systems, the sales do not appear to be slowing down and the trend is expected to continue as the price of benchtop instruments is still being dropped. These systems are largely being used for amplicon sequencing and targeted sequencing, as well as RNA or small/ micro RNA sequencing. But this rapid rate of adoption of the benchtop systems has fueled the growth for reagents and kits for these various applications. In particular, there has been a great demand for panels of genes related to specific disease areas.
Library Preparation and Target Enrichment is thus a crucial part of sequencing, and one where there are many more competitors than in the market for the instrument systems themselves. The report covers the market for Library Preparation and Target Enrichment. It lists products from over 220 companies and profiles the major players in the space among them.
Page Count: 146
Table of Contents
-
Chapter 1: Executive Summary
-
Introduction
-
Product Introductions, Indications of Price Pressure
-
Stability in Sequencers Appears to Be Continuing
-
A Period of Rapid Adoption, But Lower Prices
-
High Likelihood of Longer-Term Challenges
-
Size and Growth of the Market
-
Scope and Methodology
-
Applications and Definitions
-
Chapter 2: Trends
-
Falling Costs, Improved Output, Smaller and Simpler
-
Broad Range of Deals and Acquisitions
-
New Technologies Continuing to Push Boundaries
-
China Becoming Major Player in Market
-
More Systems Stalled or Cancelled
-
Gradual Acceptance and Validation of Clinical Applications
-
Settlement or Resolution of Litigation
-
Success in Microbiology and Pathogen Detection
-
Regulatory Trends
-
Chapter 3: Products
-
Chapter 4: Revenues
-
Revenues Forecast
-
Revenues by Region
-
Illumina Sequencing Consumables Revenues
-
Chapter 5: Competitive
-
Introduction
-
Continued Growth and Technology Advances
-
Sequencer Battles Turn Somewhat Calm
-
Library Preparation and Target Enrichment Market Shares
-
Smaller Companies Experiencing Mixed Success
-
Chapter 6: Deals
-
Chapter 7: Corporate Profiles
-
10X Genomics
-
Agilent Technologies
-
Fluidigm
-
Illumina
-
Oxford Nanopore
-
Pacific Biosciences
-
Qiagen
-
Roche
-
Thermo Fisher Scientific
-
Chapter 8: Challenges
-
Challenges
-
Highly Concentrated Sequencer Market Increases Risks
-
Challenges Arising with Clinical Trials
-
Dropping Sequencing Costs Create Complex Situations
-
Potential for Disruptive Technology or Litigation
-
Diagnoses, Treatments, Ethics Still Inexact
-
Unknown Effects of Closed Systems, Automation, Streamlining
-
Some Advances Can Reduce Markets
-
Sample Preparation Customer Loyalty Lacking
-
Shortcomings and Pitfalls Require Solutions
-
Low Barriers Can Increase Competition Short-Term
-
Cautious Approach with LDT Regulation
-
Complexity and Difficulty Restrains Broad Adoption
-
Many Labs Opting for Services over Purchasing Sequencers
-
Strategic Recommendations
-
Diversify Products and Applications
-
Expanding Market Requires Technical Support
-
Reduce Bias, Compensate, or Characterize It
-
Capitalize on Stability While Preparing for Contingencies
-
Address or Anticipate Price Pressure
-
Benefit from Partnering or Communicating
-
Use Services for Visibility and Monetization
-
Address or Ease Data Analysis Challenges
-
Anticipate or Position for Global Adoption
|
More information about this product
Other Users Also Viewed
18 Jun 2021
SKU 21-028
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare…
|